1. |
Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J, 2007, 28(1): 88-136.
|
2. |
Kaboli J, Hoth B, Mcclimon J, et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med, 2006, 166(9): 955-964.
|
3. |
Macdonald J, Stodel J, Chambers W. An online interprofessional learning resource for physicians, pharmacists, nurse practitioners, and nurses in long-term care: benefits, barriers, and lessons learned. Inform Health Soc Care, 2008, 33(1): 21-38.
|
4. |
Salter C, Holland R, Harvey I, et al. “I haven’t even phoned my doctor yet.” The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ, 2007, 334(763): 1101.
|
5. |
Royal S, Smeaton L, Avery J, et al. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care, 2006, 15(1): 23-31.
|
6. |
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
|
7. |
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002, 21(11): 1539-1558.
|
8. |
Edelman D, Fredrickson K, Melnyk D, et al. Medical clinicsversus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med, 2010, 152(11): 689-696.
|
9. |
Mclean L, Mcalister A, Johnson A, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med, 2008, 168(21): 2355-2361.
|
10. |
Simpson H, Majumdar R, Tsuyuki T, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care, 2011, 34(1): 20-26.
|
11. |
Scott M, Boyd T, Stephan M, et al. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm, 2006, 63(21): 2116-2122.
|
12. |
Pape A, Hunt S, Butler L, et al. Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med, 2011, 171(16): 1480-1486.
|
13. |
Taveira H, Friedmann D, Cohen B, et al. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ, 2010, 36(1): 109-117.
|
14. |
Clifford Rm DW, Fremantle DS. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care, 2005, 28(4): 771-776.
|
15. |
Muliira JK, D’Souza MS, Ahmed SM, et al. Barriers to colorectal cancer screening in primary care settings: attitudes and knowledge of nurses and physicians. Asia Pac J Oncol Nurs. 2016, 3(1): 98-107.
|
16. |
Zhu LL, Zhou Q. Multidisciplinary collaboration among physicians, pharmacists, nurses, and information technology engineers addresses inappropriate pill crushing and capsule opening in hospitalized patients. Int J Nurs Pract. 2016, 22(6): 660-661.
|